ASH to Collaborate on Clinical Practice Guidelines on Diagnosis, Management of von Willebrand Disease
Jun 21, 2018
The American Society of Hematology will collaborate with the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, World Federation of Hemophilia, and the University of Kansas Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease.
On World Sickle Cell Day, ASH Takes Action to Improve Global Health Outcomes
Jun 19, 2018
This World Sickle Cell Day, ASH hosted a webinar to raise global awareness about this devastating disease. Additionally, two new videos addressing the need for newborn screening and countering the prevailing myths about the disease in sub-Saharan Africa were unveiled.
JAK Inhibitors Associated with Aggressive Lymphoma
Jun 15, 2018
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.